Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Lags Revenue Estimates

Acadia (ACAD) delivered earnings and revenue surprises of -13.33% and -1.58%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock? …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.